Paper38136707
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils.
Barbarossa A and 7 others. Antibiotics (Basel), 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils. Papers, record 38136707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136707
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31399349 | Insights on the anticandidal activity of non-antifungal drugs. | J Mycol Med | 2019 | https://conductscience.org/library/papers/31399349 | PubMed |
| 2 | 20183299 | Natural products--antifungal agents derived from plants. | J Asian Nat Prod Res | 2009 | https://conductscience.org/library/papers/20183299 | PubMed |
| 3 | 10699673 | A modified microtiter-plate test for quantification of staphylococcal biofilm formation. | J Microbiol Methods | 2000 | https://conductscience.org/library/papers/10699673 | PubMed |
| 4 | 22115099 | Biofilm ecology: On-line methods bring new insights into mic and microbial biofouling. | Biofouling | 1996 | https://conductscience.org/library/papers/22115099 | PubMed |
| 5 | 19564370 | Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564370 | PubMed |
| 6 | 36421261 | Synergistic Action of Cinnamomum verum Essential Oil with Sertraline. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36421261 | PubMed |
| 7 | 29099084 | Essential Oils and Antifungal Activity. | Pharmaceuticals (Basel) | 2017 | https://conductscience.org/library/papers/29099084 | PubMed |
| 8 | 35740222 | Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35740222 | PubMed |
| 9 | 23878798 | Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23878798 | PubMed |
| 10 | 35159614 | Essential Oils and Their Major Components: An Updated Review on Antimicrobial Activities, Mechanism of Action and Their Potential Application in the Food Industry. | Foods | 2022 | https://conductscience.org/library/papers/35159614 | PubMed |
| 11 | 35899117 | Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Candida Species. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35899117 | PubMed |
| 12 | 32987638 | Anti-Biofilm Inhibitory Synergistic Effects of Combinations of Essential Oils and Antibiotics. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32987638 | PubMed |
| 13 | 32277380 | Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges. | Mycopathologia | 2020 | https://conductscience.org/library/papers/32277380 | PubMed |
| 14 | 34166776 | Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. | Int J Antimicrob Agents | 2021 | https://conductscience.org/library/papers/34166776 | PubMed |
| 15 | 31861858 | Candida spp./Bacteria Mixed Biofilms. | J Fungi (Basel) | 2019 | https://conductscience.org/library/papers/31861858 | PubMed |
| 16 | 11801575 | Amphotericin B: spectrum and resistance. | J Antimicrob Chemother | 2002 | https://conductscience.org/library/papers/11801575 | PubMed |
| 17 | 34201271 | Synergistic Activity of New Diclofenac and Essential Oils Combinations against Different Candida spp. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34201271 | PubMed |
| 18 | 22291693 | Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components. | Front Microbiol | 2012 | https://conductscience.org/library/papers/22291693 | PubMed |
| 19 | 32047294 | Drug resistance and tolerance in fungi. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32047294 | PubMed |
| 20 | 34346716 | Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST). | J Clin Microbiol | 2022 | https://conductscience.org/library/papers/34346716 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41463762 | Exploring the Antibacterial, Anti-Inflammatory, and Antioxidant Properties of the Natural Food Supplement "Protegol" as a Supportive Strategy in Respiratory Tract Infections. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41463762 | PubMed |
| 40426569 | Essential Oils for Biofilm Control: Mechanisms, Synergies, and Translational Challenges in the Era of Antimicrobial Resistance. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40426569 | PubMed |
| 40333114 | Synergistic Antibacterial Effects of Plant Extracts and Essential Oils Against Drug-Resistant Bacteria of Clinical Interest. | Pathogens | 2025 | https://conductscience.org/library/papers/40333114 | PubMed |
| 40313147 | Antifungal effects of Metformin against Candida albicans by autophagy regulation. | J Microbiol | 2025 | https://conductscience.org/library/papers/40313147 | PubMed |
| 40298618 | Investigating Bergamot Essential Oil (BEO) Properties: Cytoprotection in Neuronal Cells Exposed to Heavy Metals and Antibacterial Activities. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40298618 | PubMed |
| 40005818 | Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus. | Microorganisms | 2025 | https://conductscience.org/library/papers/40005818 | PubMed |
| 40001361 | Efficacy of Willow Herb (Epilobium angustifolium L. and E. parviflorum Schreb.) Crude and Purified Extracts and Oenothein B Against Prostatic Pathogens. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40001361 | PubMed |
| 39338275 | Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39338275 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136707
GET https://conductscience.org/api/papers/v1/38136707/references?page=2